MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$1,076K
Net Income
$200,636K
Net Profit Margin
18646.47%
EPS
$49.61
Unit: Thousand (K) dollars
Revenue Breakdown
Drug Product Revenue
Development And Other Revenue
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-09-30
Total revenue
1,076
1,348
2,739
46,333
Cost of goods sold
-58
85
252
5,295
Research and development
1,209
5,865
9,175
21,708
Selling, general and administrative
5,295
7,057
8,106
17,554
Restructuring charge
41
393
126
18,554
Total operating costs and expenses
6,487
13,400
17,659
63,111
Loss from operations
-5,411
-12,052
-14,920
-16,778
Interest expense
2,083
2,009
2,257
4,994
Loss on debt extinguishments
-6,583
-
-
-
Interest income and other income (expenses), net
931
286
413
3,802
Total interest and other, net
-7,735
-1,723
-1,844
-1,192
Loss from continuing operations before income taxes
-13,146
-13,775
-16,764
-17,970
Investment income (loss)
-
-
-
898
Provision for (benefit from) income taxes
0
-92
2
12
Loss from continuing operations
-13,146
-13,683
-16,766
-
Income from discontinued operations, net of tax
213,782
6,080
21,405
-
Net income (loss)
200,636
-7,603
4,639
-17,084
Basic EPS
49.61
-1.88
0.05
-0.17
Diluted EPS
49.61
-1.88
0.05
-0.17
Basic Average Shares
4,044,000
4,042,000
100,954,000
100,515,000
Diluted Average Shares
4,044,000
4,042,000
100,954,000
100,515,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Income from
discontinued operations, net...
$213,782K
Net income (loss)
$200,636K
(1274.41%↑ Y/Y)
Loss from continuing
operations
-$13,146K
Loss from continuing
operations before income...
-$13,146K
(26.84%↑ Y/Y)
Drug Product Revenue
$957K
Development And Other
Revenue
$119K
Total interest and
other, net
-$7,735K
(-548.91%↓ Y/Y)
Loss from operations
-$5,411K
(67.75%↑ Y/Y)
Interest income and other
income (expenses), net
$931K
(-75.51%↓ Y/Y)
Total revenue
$1,076K
(-97.68%↓ Y/Y)
Loss on debt
extinguishments
-$6,583K
Interest expense
$2,083K
(-58.29%↓ Y/Y)
Total operating costs
and expenses
$6,487K
(-89.72%↓ Y/Y)
Cost of goods sold
-$58K
(-101.10%↓ Y/Y)
Selling, general and
administrative
$5,295K
(-69.84%↓ Y/Y)
Research and development
$1,209K
(-94.43%↓ Y/Y)
Restructuring charge
$41K
(-99.78%↓ Y/Y)
Buy us a coffee
FIBROGEN INC (FGEN)
FIBROGEN INC (FGEN)